Drug intelligence / Profile preview

methylene blue + ozone

Development stage
Phase 4
Lead developer
Assiut University
Modality
Small Molecules
Administration
Intravenous, Extracorporeal
01

Overview

methylene blue + ozone is a combination therapeutic approach investigated by Assiut University for the management of early sepsis. Methylene blue is a small molecule that acts as an inhibitor of inducible nitric oxide synthase (iNOS) and soluble guanylate cyclase, helping to counteract the vasodilation and hypotension associated with septic shock by reducing the overproduction of nitric oxide and cyclic guanosine monophosphate (cGMP). Ozone (O3) therapy is utilized for its potential immune-modulatory and antioxidant properties, which are thought to help regulate the inflammatory response in sepsis. This combination was evaluated in a Phase 4 clinical trial (NCT02910765) to assess its impact on clinical outcomes such as APACHE scores, duration of ICU stay, and mortality in adult patients with early sepsis.

Other names
Methylene Blue and Ozone in Early Sepsis
02

Targets

NOS1 (nNOS)sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on methylene blue + ozone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylene blue + ozone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call